| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |